Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Hultafors Group AB in connection with the acquisition of Fristads, Kansas and Leijona
Mandate

Vinge advises Hultafors Group AB in connection with the acquisition of Fristads, Kansas and Leijona

May 12, 2021 M&A

The acquisition of Fristads, Kansas and Leijona is part of Hultafors Group’s strategy for growth and development of leading trademarks within the personal security equipment segment in Europe and North America.

Hultafors Group’s products, which include, among other things, protective clothing and protective equipment, are sold to professional users.

The acquisition was completed in March 2021 and Vinge’s team was headed by advokat Wibeke Sorling,  advokat and partner Anna Palmérus, advokat Petronella Hallberg, associate Jenny Sandlund, advokat Alexander Lindeberg as well as associates Victoria Gunnerek, Hanna Marberg and Jacob Benzow.

Related

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

 Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026